Skip to main content
Erschienen in: Clinical Research in Cardiology 8/2019

14.02.2019 | Original Paper

Non-invasive evaluation of the relationship between electrical and structural cardiac abnormalities in patients with myotonic dystrophy type 1

verfasst von: Lukas Chmielewski, Michael Bietenbeck, Alexandru Patrascu, Sabine Rösch, Udo Sechtem, Ali Yilmaz, Anca-Rezeda Florian

Erschienen in: Clinical Research in Cardiology | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Cardiac involvement in myotonic dystrophy type 1 (MD1) includes conduction disease, arrhythmias, and left-ventricular (LV) systolic dysfunction leading to an increased sudden cardiac death risk. An understanding of the interplay between electrical and structural myocardial changes could improve the prediction of adverse cardiac events. We aimed to explore the relationship between signs of cardiomyopathy by conventional and advanced cardiovascular magnetic resonance (CMR), and electrical abnormalities in MD1.

Methods

Fifty-seven MD1 patients (43 ± 13 years, 46% male) and 15 matched controls (41 ± 7 years, 53% male) underwent CMR including cine-imaging with feature-tracking strain analysis, late gadolinium enhancement (LGE), and native/post-contrast T1-mapping with extracellular volume calculation. Standard 12-lead and long-term ECG monitoring were performed as screening for rhythm and/or conduction abnormalities.

Results

Abnormal ECGs were recorded in 40% of MD1; a pathologic CMR was found in 44%: 21% had an impaired LV–EF and 32% showed non-ischemic LGE. When looking at MD1 patients with available long-term ECG monitoring (n = 39), those with atrial fibrillation (Afib)/flutter(Afl) episodes had lower LV–EF (52 ± 7 vs. 60 ± 5%, p = 0.002), lower global longitudinal strain (− 17 ± 3 vs. − 20 ± 3%, p = 0.034), a trend to lower left atrial emptying fraction (LA–EF) (44 ± 14 vs. 55 ± 8%, p = 0.08), and higher prevalence of LGE (88% vs. 23%, p = 0.001) with an intramural (75% vs. 23%, p = 0.01) and septal (63% vs. 13%, p = 0.009) pattern. In a model including LV–EF (OR 0.8, 95% CI 0.7–1.0, p = NS) and LGE presence (OR 14.8, 95% CI 1.4–159.0, p = 0.026), only LGE was independently associated with the occurrence of Afib/Afl episodes.

Conclusion

Myocardial abnormalities depicted by non-ischemic LGE-CMR were the only independent predictor for the occurrence of Afib/Afl on ECG monitoring, previously shown to predict adverse cardiac events in MD1.
Literatur
2.
Zurück zum Zitat Lund M, Diaz LJ, Ranthe MF, Petri H, Duno M, Juncker I et al (2014) Cardiac involvement in myotonic dystrophy: a nationwide cohort study. Eur Heart J 35:2158–2164CrossRefPubMed Lund M, Diaz LJ, Ranthe MF, Petri H, Duno M, Juncker I et al (2014) Cardiac involvement in myotonic dystrophy: a nationwide cohort study. Eur Heart J 35:2158–2164CrossRefPubMed
3.
Zurück zum Zitat Petri H, Ahtarovski KA, Vejlstrup N, Vissing J, Witting N, Køber L, Bundgaard H (2014) Myocardial fibrosis in patients with myotonic dystrophy type 1: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 16:59CrossRefPubMedPubMedCentral Petri H, Ahtarovski KA, Vejlstrup N, Vissing J, Witting N, Køber L, Bundgaard H (2014) Myocardial fibrosis in patients with myotonic dystrophy type 1: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 16:59CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Groh WJ, Groh MR, Saha C, Kincaid JC, Simmons Z, Ciafaloni E et al (2008) Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. N Engl J Med 358:2688–2697CrossRefPubMed Groh WJ, Groh MR, Saha C, Kincaid JC, Simmons Z, Ciafaloni E et al (2008) Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. N Engl J Med 358:2688–2697CrossRefPubMed
5.
Zurück zum Zitat Petri H, Vissing J, Witting N, Bundgaard H, Køber L (2012) Cardiac manifestations of myotonic dystrophy type 1. Int J Cardiol 160:82–88CrossRefPubMed Petri H, Vissing J, Witting N, Bundgaard H, Køber L (2012) Cardiac manifestations of myotonic dystrophy type 1. Int J Cardiol 160:82–88CrossRefPubMed
6.
Zurück zum Zitat Petri H, Witting N, Ersbøll MK, Sajadieh A, Dunø M, Helweg-Larsen S et al (2014) High prevalence of cardiac involvement in patients with myotonic dystrophy type 1: a cross-sectional study. Int J Cardiol 174:31–36CrossRefPubMed Petri H, Witting N, Ersbøll MK, Sajadieh A, Dunø M, Helweg-Larsen S et al (2014) High prevalence of cardiac involvement in patients with myotonic dystrophy type 1: a cross-sectional study. Int J Cardiol 174:31–36CrossRefPubMed
7.
Zurück zum Zitat Wahbi K, Babuty D, Probst V, Wissocque L, Labombarda F, Porcher R et al (2017) Incidence and predictors of sudden death, major conduction defects and sustained ventricular tachyarrhythmias in 1388 patients with myotonic dystrophy type 1. Eur Heart J 38:751–758PubMed Wahbi K, Babuty D, Probst V, Wissocque L, Labombarda F, Porcher R et al (2017) Incidence and predictors of sudden death, major conduction defects and sustained ventricular tachyarrhythmias in 1388 patients with myotonic dystrophy type 1. Eur Heart J 38:751–758PubMed
8.
Zurück zum Zitat Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt O-A et al (2013) 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J 34:2281–2329CrossRefPubMed Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt O-A et al (2013) 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J 34:2281–2329CrossRefPubMed
9.
Zurück zum Zitat Valaperta R, Gaeta M, Cardani R, Lombardi F, Rampoldi B, Siena C de et al (2016) High-sensitive cardiac troponin T (hs-cTnT) assay as serum biomarker to predict cardiac risk in myotonic dystrophy: a case-control study. Clin Chim Acta 463:122–128CrossRefPubMed Valaperta R, Gaeta M, Cardani R, Lombardi F, Rampoldi B, Siena C de et al (2016) High-sensitive cardiac troponin T (hs-cTnT) assay as serum biomarker to predict cardiac risk in myotonic dystrophy: a case-control study. Clin Chim Acta 463:122–128CrossRefPubMed
10.
Zurück zum Zitat Bhakta D, Groh MR, Shen C, Pascuzzi RM, Groh WJ (2010) Increased mortality with left ventricular systolic dysfunction and heart failure in adults with myotonic dystrophy type 1. Am Heart J 160:1137–1141, 1141.e1CrossRefPubMed Bhakta D, Groh MR, Shen C, Pascuzzi RM, Groh WJ (2010) Increased mortality with left ventricular systolic dysfunction and heart failure in adults with myotonic dystrophy type 1. Am Heart J 160:1137–1141, 1141.e1CrossRefPubMed
11.
Zurück zum Zitat Bhakta D, Lowe MR, Groh WJ (2004) Prevalence of structural cardiac abnormalities in patients with myotonic dystrophy type I. Am Heart J 147:224–227CrossRefPubMed Bhakta D, Lowe MR, Groh WJ (2004) Prevalence of structural cardiac abnormalities in patients with myotonic dystrophy type I. Am Heart J 147:224–227CrossRefPubMed
12.
Zurück zum Zitat Nguyen HH, Wolfe JT, Holmes DR, Edwards WD (1988) Pathology of the cardiac conduction system in myotonic dystrophy: a study of 12 cases. J Am Coll Cardiol 11:662–671CrossRefPubMed Nguyen HH, Wolfe JT, Holmes DR, Edwards WD (1988) Pathology of the cardiac conduction system in myotonic dystrophy: a study of 12 cases. J Am Coll Cardiol 11:662–671CrossRefPubMed
13.
Zurück zum Zitat Rakocević-Stojanović V, Pavlović S, Seferović P, Vasiljević J, Lavrnić D, Marinković Z, Apostolski S (1999) Pathohistological changes in endomyocardial biopsy specimens in patients with myotonic dystrophy. Panminerva Med 41:27–30PubMed Rakocević-Stojanović V, Pavlović S, Seferović P, Vasiljević J, Lavrnić D, Marinković Z, Apostolski S (1999) Pathohistological changes in endomyocardial biopsy specimens in patients with myotonic dystrophy. Panminerva Med 41:27–30PubMed
14.
Zurück zum Zitat Choudhary P, Nandakumar R, Greig H, Broadhurst P, Dean J, Puranik R et al (2016) Structural and electrical cardiac abnormalities are prevalent in asymptomatic adults with myotonic dystrophy. Heart 102:1472–1478CrossRefPubMed Choudhary P, Nandakumar R, Greig H, Broadhurst P, Dean J, Puranik R et al (2016) Structural and electrical cardiac abnormalities are prevalent in asymptomatic adults with myotonic dystrophy. Heart 102:1472–1478CrossRefPubMed
15.
Zurück zum Zitat Hermans MCE, Faber CG, Bekkers SCAM, Die-Smulders CEM de, Gerrits MM, Merkies ISJ et al (2012) Structural and functional cardiac changes in myotonic dystrophy type 1: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 14:48CrossRefPubMedPubMedCentral Hermans MCE, Faber CG, Bekkers SCAM, Die-Smulders CEM de, Gerrits MM, Merkies ISJ et al (2012) Structural and functional cardiac changes in myotonic dystrophy type 1: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 14:48CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Motwani M, Kidambi A, Greenwood JP, Plein S (2014) Advances in cardiovascular magnetic resonance in ischaemic heart disease and non-ischaemic cardiomyopathies. Heart 100:1722–1733CrossRefPubMed Motwani M, Kidambi A, Greenwood JP, Plein S (2014) Advances in cardiovascular magnetic resonance in ischaemic heart disease and non-ischaemic cardiomyopathies. Heart 100:1722–1733CrossRefPubMed
17.
Zurück zum Zitat Miller CA, Naish JH, Bishop P, Coutts G, Clark D, Zhao S et al (2013) Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume. Circ Cardiovasc Imaging 6:373–383CrossRefPubMed Miller CA, Naish JH, Bishop P, Coutts G, Clark D, Zhao S et al (2013) Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume. Circ Cardiovasc Imaging 6:373–383CrossRefPubMed
18.
Zurück zum Zitat Taylor RJ, Moody WE, Umar F, Edwards NC, Taylor TJ, Stegemann B et al (2015) Myocardial strain measurement with feature-tracking cardiovascular magnetic resonance: normal values. Eur Heart J Cardiovasc Imaging 16:871–881CrossRefPubMed Taylor RJ, Moody WE, Umar F, Edwards NC, Taylor TJ, Stegemann B et al (2015) Myocardial strain measurement with feature-tracking cardiovascular magnetic resonance: normal values. Eur Heart J Cardiovasc Imaging 16:871–881CrossRefPubMed
19.
Zurück zum Zitat Florian A, Ludwig A, Engelen M, Waltenberger J, Rösch S, Sechtem U, Yilmaz A (2014) Left ventricular systolic function and the pattern of late-gadolinium-enhancement independently and additively predict adverse cardiac events in muscular dystrophy patients. J Cardiovasc Magn Reson 16:81CrossRefPubMedPubMedCentral Florian A, Ludwig A, Engelen M, Waltenberger J, Rösch S, Sechtem U, Yilmaz A (2014) Left ventricular systolic function and the pattern of late-gadolinium-enhancement independently and additively predict adverse cardiac events in muscular dystrophy patients. J Cardiovasc Magn Reson 16:81CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Hudsmith LE, Petersen SE, Francis JM, Robson MD, Neubauer S (2005) Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging. J Cardiovasc Magn Reson 7:775–782CrossRefPubMed Hudsmith LE, Petersen SE, Francis JM, Robson MD, Neubauer S (2005) Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging. J Cardiovasc Magn Reson 7:775–782CrossRefPubMed
21.
Zurück zum Zitat Blume GG, Mcleod CJ, Barnes ME, Seward JB, Pellikka PA, Bastiansen PM, Tsang TSM (2011) Left atrial function: physiology, assessment, and clinical implications. Eur J Echocardiogr 12:421–430CrossRefPubMed Blume GG, Mcleod CJ, Barnes ME, Seward JB, Pellikka PA, Bastiansen PM, Tsang TSM (2011) Left atrial function: physiology, assessment, and clinical implications. Eur J Echocardiogr 12:421–430CrossRefPubMed
22.
Zurück zum Zitat Kawel-Boehm N, Maceira A, Valsangiacomo-Buechel ER, Vogel-Claussen J, Turkbey EB, Williams R et al (2015) Normal values for cardiovascular magnetic resonance in adults and children. J Cardiovasc Magn Reson 17:29CrossRefPubMedPubMedCentral Kawel-Boehm N, Maceira A, Valsangiacomo-Buechel ER, Vogel-Claussen J, Turkbey EB, Williams R et al (2015) Normal values for cardiovascular magnetic resonance in adults and children. J Cardiovasc Magn Reson 17:29CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Habibi M, Chahal H, Opdahl A, Gjesdal O, Helle-Valle TM, Heckbert SR et al (2014) Association of CMR-measured LA function with heart failure development: results from the MESA study. JACC Cardiovasc Imaging 7:570–579CrossRefPubMedPubMedCentral Habibi M, Chahal H, Opdahl A, Gjesdal O, Helle-Valle TM, Heckbert SR et al (2014) Association of CMR-measured LA function with heart failure development: results from the MESA study. JACC Cardiovasc Imaging 7:570–579CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Groh WJ, Lowe MR, Zipes DP (2002) Severity of cardiac conduction involvement and arrhythmias in myotonic dystrophy type 1 correlates with age and CTG repeat length. J Cardiovasc Electrophysiol 13:444–448CrossRefPubMed Groh WJ, Lowe MR, Zipes DP (2002) Severity of cardiac conduction involvement and arrhythmias in myotonic dystrophy type 1 correlates with age and CTG repeat length. J Cardiovasc Electrophysiol 13:444–448CrossRefPubMed
26.
Zurück zum Zitat Florian A, Ludwig A, Rösch S, Yildiz H, Sechtem U, Yilmaz A (2014) Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging. Eur Heart J Cardiovasc Imaging 15:1004–1012CrossRefPubMed Florian A, Ludwig A, Rösch S, Yildiz H, Sechtem U, Yilmaz A (2014) Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging. Eur Heart J Cardiovasc Imaging 15:1004–1012CrossRefPubMed
27.
Zurück zum Zitat Garcia R, Rehman M, Goujeau C, Degand B, Le Gal F, Stordeur B et al (2017) Left ventricular longitudinal strain impairment predicts cardiovascular events in asymptomatic type 1 myotonic dystrophy. Int J Cardiol 243:424–430CrossRefPubMed Garcia R, Rehman M, Goujeau C, Degand B, Le Gal F, Stordeur B et al (2017) Left ventricular longitudinal strain impairment predicts cardiovascular events in asymptomatic type 1 myotonic dystrophy. Int J Cardiol 243:424–430CrossRefPubMed
28.
Zurück zum Zitat Sado DM, White SK, Piechnik SK, Banypersad SM, Treibel T, Captur G et al (2013) Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping. Circ Cardiovasc Imaging 6:392–398CrossRefPubMed Sado DM, White SK, Piechnik SK, Banypersad SM, Treibel T, Captur G et al (2013) Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping. Circ Cardiovasc Imaging 6:392–398CrossRefPubMed
29.
Zurück zum Zitat Turkbey EB, Gai N, Lima JAC, van der Geest RJ, Wagner KR, Tomaselli GF et al (2012) Assessment of cardiac involvement in myotonic muscular dystrophy by T1 mapping on magnetic resonance imaging. Heart Rhythm 9:1691–1697CrossRefPubMedPubMedCentral Turkbey EB, Gai N, Lima JAC, van der Geest RJ, Wagner KR, Tomaselli GF et al (2012) Assessment of cardiac involvement in myotonic muscular dystrophy by T1 mapping on magnetic resonance imaging. Heart Rhythm 9:1691–1697CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Sommerville RB, Vincenti MG, Winborn K, Casey A, Stitziel NO, Connolly AM, Mann DL (2017) Diagnosis and management of adult hereditary cardio-neuromuscular disorders: a model for the multidisciplinary care of complex genetic disorders. Trends Cardiovasc Med 27:51–58CrossRefPubMed Sommerville RB, Vincenti MG, Winborn K, Casey A, Stitziel NO, Connolly AM, Mann DL (2017) Diagnosis and management of adult hereditary cardio-neuromuscular disorders: a model for the multidisciplinary care of complex genetic disorders. Trends Cardiovasc Med 27:51–58CrossRefPubMed
31.
Zurück zum Zitat Merlevede K, Vermander D, Theys P, Legius E, Ector H, Robberecht W (2002) Cardiac involvement and CTG expansion in myotonic dystrophy. J Neurol 249:693–698CrossRefPubMed Merlevede K, Vermander D, Theys P, Legius E, Ector H, Robberecht W (2002) Cardiac involvement and CTG expansion in myotonic dystrophy. J Neurol 249:693–698CrossRefPubMed
32.
Zurück zum Zitat Russo V, Rago A, Ciardiello C, Russo MG, Calabrò P, Politano L, Nigro G (2016) The role of the atrial electromechanical delay in predicting atrial fibrillation in myotonic dystrophy type 1 patients. J Cardiovasc Electrophysiol 27:65–72CrossRefPubMed Russo V, Rago A, Ciardiello C, Russo MG, Calabrò P, Politano L, Nigro G (2016) The role of the atrial electromechanical delay in predicting atrial fibrillation in myotonic dystrophy type 1 patients. J Cardiovasc Electrophysiol 27:65–72CrossRefPubMed
33.
Zurück zum Zitat Haeusler KG, Gröschel K, Köhrmann M, Anker SD, Brachmann J, Böhm M et al (2018) Expert opinion paper on atrial fibrillation detection after ischemic stroke. Clin Res Cardiol 107:871–880CrossRefPubMed Haeusler KG, Gröschel K, Köhrmann M, Anker SD, Brachmann J, Böhm M et al (2018) Expert opinion paper on atrial fibrillation detection after ischemic stroke. Clin Res Cardiol 107:871–880CrossRefPubMed
35.
Zurück zum Zitat Bettin M, Dechering D, Kochhäuser S, Bode N, Eckardt L, Frommeyer G, Reinke F (2018) Extended ECG monitoring with an implantable loop recorder in patients with cryptogenic stroke: time schedule, reasons for explantation and incidental findings (results from the TRACK-AF trial). Clin Res Cardiol. https://doi.org/10.1007/s00392-018-1358-4 CrossRefPubMed Bettin M, Dechering D, Kochhäuser S, Bode N, Eckardt L, Frommeyer G, Reinke F (2018) Extended ECG monitoring with an implantable loop recorder in patients with cryptogenic stroke: time schedule, reasons for explantation and incidental findings (results from the TRACK-AF trial). Clin Res Cardiol. https://​doi.​org/​10.​1007/​s00392-018-1358-4 CrossRefPubMed
36.
Zurück zum Zitat Puntmann VO, Peker E, Chandrashekhar Y, Nagel E (2016) T1 mapping in characterizing myocardial disease: a comprehensive review. Circ Res 119:277–299CrossRefPubMed Puntmann VO, Peker E, Chandrashekhar Y, Nagel E (2016) T1 mapping in characterizing myocardial disease: a comprehensive review. Circ Res 119:277–299CrossRefPubMed
Metadaten
Titel
Non-invasive evaluation of the relationship between electrical and structural cardiac abnormalities in patients with myotonic dystrophy type 1
verfasst von
Lukas Chmielewski
Michael Bietenbeck
Alexandru Patrascu
Sabine Rösch
Udo Sechtem
Ali Yilmaz
Anca-Rezeda Florian
Publikationsdatum
14.02.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Research in Cardiology / Ausgabe 8/2019
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-019-01414-0

Weitere Artikel der Ausgabe 8/2019

Clinical Research in Cardiology 8/2019 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.